![]()
|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Biol Chem, Vol. 275, Issue 20, 15254-15264, May 19, 2000
From the Departments of Histone acetylation alters chromatin state by
modifying lysines on histone and plays an important role in modulating
gene transcription. A dynamic balance of histone
acetylation/deacetylation is maintained by histone acetyltransferases
and histone deacetylases. Emerging evidence suggests that a family of
histone deacetylases may exist to regulate diverse cellular functions,
including chromatin structure, gene expression, cell cycle progression,
and oncogenesis. We describe here a novel human histone deacetylase,
named HDAC8, cloned from human kidney. HDAC8 encodes 377 amino acid
residues and shares extensive homology to several known HDACs, in
particular a histone deacetylase from Arabidopsis
thaliana. Northern blot analyses revealed that HDAC8
expression pattern for HDAC8 is distinct from that for HDAC1 and HDAC3,
and expression of HDAC8 mRNA occurs in multiple organs including
heart, lung, kidney, and pancreas. HDAC8 mRNA was also observed in
several cell lines derived from cancerous tissues. When expressed in
HEK293 cells, HDAC8 exhibited deacetylase activity toward acetylated
histone, indicating that this protein is a bona fide
histone deacetylase. Its histone deacetylase activity was inhibited by
trichostatin and other known histone deacetylase inhibitors.
Furthermore, active recombinant HDAC8 was expressed and purified from
Escherichia coli. When ectopically expressed in cells,
HDAC8 was found to be localized to the nucleus. Co-transfection
experiments demonstrated that expression of HDAC8 repressed a viral
SV40 early promoter activity. These results indicate that HDAC8 is a
novel member of the histone deacetylase family, which may play a role
in the development of a broad range of tissues and potentially in the
etiology of cancer.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF230097.
Cloning and Characterization of a Novel Human Class I Histone
Deacetylase That Functions as a Transcription Repressor*
§,
,
,
,
,
,
, and
Renal Pharmacology,
** Oncology, ¶ Molecular Biology,

Medicinal Chemistry, and
Gene
Expression Sciences, SmithKline Beecham Pharmaceuticals,
King of Prussia, Pennsylvania 19403
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
M. Fournel, C. Bonfils, Y. Hou, P. T. Yan, M.-C. Trachy-Bourget, A. Kalita, J. Liu, A.-H. Lu, N. Z. Zhou, M.-F. Robert, et al. MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo Mol. Cancer Ther., April 1, 2008; 7(4): 759 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Fukuda, N. Sano, S. Muto, and M. Horikoshi Simple histone acetylation plays a complex role in the regulation of gene expression. Brief Funct Genomic Proteomic, September 1, 2006; 5(3): 190 - 208. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lee, N. Sengupta, A. Villagra, N. Rezai-Zadeh, and E. Seto Histone Deacetylase 8 Safeguards the Human Ever-Shorter Telomeres 1B (hEST1B) Protein from Ubiquitin-Mediated Degradation. Mol. Cell. Biol., July 1, 2006; 26(14): 5259 - 5269. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Basile, R. Mantovani, and C. Imbriano DNA Damage Promotes Histone Deacetylase 4 Nuclear Localization and Repression of G2/M Promoters, via p53 C-terminal Lysines J. Biol. Chem., January 27, 2006; 281(4): 2347 - 2357. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. C. Ryan, D. Headlee, M. Acharya, A. Sparreboom, J. B. Trepel, J. Ye, W. D. Figg, K. Hwang, E. J. Chung, A. Murgo, et al. Phase I and Pharmacokinetic Study of MS-275, a Histone Deacetylase Inhibitor, in Patients With Advanced and Refractory Solid Tumors or Lymphoma J. Clin. Oncol., June 10, 2005; 23(17): 3912 - 3922. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vannini, C. Volpari, G. Filocamo, E. C. Casavola, M. Brunetti, D. Renzoni, P. Chakravarty, C. Paolini, R. De Francesco, P. Gallinari, et al. Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor PNAS, October 19, 2004; 101(42): 15064 - 15069. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Schroeder, R. A. Kahler, X. Li, and J. J. Westendorf Histone Deacetylase 3 Interacts with Runx2 to Repress the Osteocalcin Promoter and Regulate Osteoblast Differentiation J. Biol. Chem., October 1, 2004; 279(40): 41998 - 42007. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Waltregny, L. de Leval, W. Glenisson, S. Ly Tran, B. J. North, A. Bellahcene, U. Weidle, E. Verdin, and V. Castronovo Expression of Histone Deacetylase 8, a Class I Histone Deacetylase, Is Restricted to Cells Showing Smooth Muscle Differentiation in Normal Human Tissues Am. J. Pathol., August 1, 2004; 165(2): 553 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Kurtev, R. Margueron, K. Kroboth, E. Ogris, V. Cavailles, and C. Seiser Transcriptional Regulation by the Repressor of Estrogen Receptor Activity via Recruitment of Histone Deacetylases J. Biol. Chem., June 4, 2004; 279(23): 24834 - 24843. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hildmann, M. Ninkovic, R. Dietrich, D. Wegener, D. Riester, T. Zimmermann, O. M. Birch, C. Bernegger, P. Loidl, and A. Schwienhorst A New Amidohydrolase from Bordetella or Alcaligenes Strain FB188 with Similarities to Histone Deacetylases J. Bacteriol., April 15, 2004; 186(8): 2328 - 2339. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lee, N. Rezai-Zadeh, and E. Seto Negative Regulation of Histone Deacetylase 8 Activity by Cyclic AMP-Dependent Protein Kinase A Mol. Cell. Biol., January 15, 2004; 24(2): 765 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Hu, E. Dul, C.-M. Sung, Z. Chen, R. Kirkpatrick, G.-F. Zhang, K. Johanson, R. Liu, A. Lago, G. Hofmann, et al. Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 720 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Scott and S. E. Plon Loss of Sin3/Rpd3 Histone Deacetylase Restores the DNA Damage Response in Checkpoint-Deficient Strains of Saccharomyces cerevisiae Mol. Cell. Biol., July 1, 2003; 23(13): 4522 - 4531. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Petrie, F. Guidez, L. Howell, L. Healy, S. Waxman, M. Greaves, and A. Zelent The Histone Deacetylase 9 Gene Encodes Multiple Protein Isoforms J. Biol. Chem., April 25, 2003; 278(18): 16059 - 16072. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Kao, W. G. McKenna, M. G. Guenther, R. J. Muschel, M. A. Lazar, and T. J. Yen Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response J. Cell Biol., March 31, 2003; 160(7): 1017 - 1027. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Danesi, F. De Braud, S. Fogli, T. M. De Pas, A. Di Paolo, G. Curigliano, and M. Del Tacca Pharmacogenetics of Anticancer Drug Sensitivity in Non-Small Cell Lung Cancer Pharmacol. Rev., March 1, 2003; 55(1): 57 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ding, L. L. Gillespie, and G. D. Paterno Human MI-ER1 Alpha and Beta Function as Transcriptional Repressors by Recruitment of Histone Deacetylase 1 to Their Conserved ELM2 Domain Mol. Cell. Biol., January 1, 2003; 23(1): 250 - 258. [Abstract] [Full Text] |
||||
![]() |
H.-m. Lin, L. Zhao, and S.-y. Cheng Cyclin D1 Is a Ligand-independent Co-repressor for Thyroid Hormone Receptors J. Biol. Chem., August 2, 2002; 277(32): 28733 - 28741. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fournel, M.-C. Trachy-Bourget, P. T. Yan, A. Kalita, C. Bonfils, C. Beaulieu, S. Frechette, S. Leit, E. Abou-Khalil, S.-H. Woo, et al. Sulfonamide Anilides, a Novel Class of Histone Deacetylase Inhibitors, Are Antiproliferative against Human Tumors Cancer Res., August 1, 2002; 62(15): 4325 - 4330. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gao, M. A. Cueto, F. Asselbergs, and P. Atadja Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family J. Biol. Chem., July 5, 2002; 277(28): 25748 - 25755. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. He and D. M. Margolis Counterregulation of Chromatin Deacetylation and Histone Deacetylase Occupancy at the Integrated Promoter of Human Immunodeficiency Virus Type 1 (HIV-1) by the HIV-1 Repressor YY1 and HIV-1 Activator Tat Mol. Cell. Biol., May 1, 2002; 22(9): 2965 - 2973. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-M. Yang, S.-C. Tsai, Y.-D. Wen, G. Fejer, and E. Seto Functional Domains of Histone Deacetylase-3 J. Biol. Chem., March 8, 2002; 277(11): 9447 - 9454. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Tong, J. Liu, N. R. Bertos, and X.-J. Yang Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain Nucleic Acids Res., March 1, 2002; 30(5): 1114 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Guardiola and T.-P. Yao Molecular Cloning and Characterization of a Novel Histone Deacetylase HDAC10 J. Biol. Chem., January 25, 2002; 277(5): 3350 - 3356. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. H. Pflum, J. K. Tong, W. S. Lane, and S. L. Schreiber Histone Deacetylase 1 Phosphorylation Promotes Enzymatic Activity and Complex Formation J. Biol. Chem., December 7, 2001; 276(50): 47733 - 47741. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Amann, J. Nip, D. K. Strom, B. Lutterbach, H. Harada, N. Lenny, J. R. Downing, S. Meyers, and S. W. Hiebert ETO, a Target of t(8;21) in Acute Leukemia, Makes Distinct Contacts with Multiple Histone Deacetylases and Binds mSin3A through Its Oligomerization Domain Mol. Cell. Biol., October 1, 2001; 21(19): 6470 - 6483. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ozawa, M. Towatari, S. Tsuzuki, F. Hayakawa, T. Maeda, Y. Miyata, M. Tanimoto, and H. Saito Histone deacetylase 3 associates with and represses the transcription factor GATA-2 Blood, October 1, 2001; 98(7): 2116 - 2123. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Guenther, O. Barak, and M. A. Lazar The SMRT and N-CoR Corepressors Are Activating Cofactors for Histone Deacetylase 3 Mol. Cell. Biol., September 15, 2001; 21(18): 6091 - 6101. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhou, P. A. Marks, R. A. Rifkind, and V. M. Richon Cloning and characterization of a histone deacetylase, HDAC9 PNAS, September 4, 2001; (2001) 191375098. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. Wang and X.-J. Yang Histone Deacetylase 4 Possesses Intrinsic Nuclear Import and Export Signals Mol. Cell. Biol., September 1, 2001; 21(17): 5992 - 6005. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Miska, E. Langley, D. Wolf, C. Karlsson, J. Pines, and T. Kouzarides Differential localization of HDAC4 orchestrates muscle differentiation Nucleic Acids Res., August 15, 2001; 29(16): 3439 - 3447. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Franco, M. Farooqui, E. Seto, and L.-N. Wei The Orphan Nuclear Receptor TR2 Interacts Directly with Both Class I and Class II Histone Deacetylases Mol. Endocrinol., August 1, 2001; 15(8): 1318 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Komatsu, K.-y. Tomizaki, M. Tsukamoto, T. Kato, N. Nishino, S. Sato, T. Yamori, T. Tsuruo, R. Furumai, M. Yoshida, et al. Cyclic Hydroxamic-acid-containing Peptide 31, a Potent Synthetic Histone Deacetylase Inhibitor with Antitumor Activity Cancer Res., June 1, 2001; 61(11): 4459 - 4466. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Wade Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin Hum. Mol. Genet., April 1, 2001; 10(7): 693 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Furumai, Y. Komatsu, N. Nishino, S. Khochbin, M. Yoshida, and S. Horinouchi Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin PNAS, December 22, 2000; (2000) 11405598. [Abstract] [Full Text] |
||||
![]() |
A. H. Wang, M. J. Kruhlak, J. Wu, N. R. Bertos, M. Vezmar, B. I. Posner, D. P. Bazett-Jones, and X.-J. Yang Regulation of Histone Deacetylase 4 by Binding of 14-3-3 Proteins Mol. Cell. Biol., September 15, 2000; 20(18): 6904 - 6912. [Abstract] [Full Text] |
||||
![]() |
H.-D. Youn, C. M. Grozinger, and J. O. Liu Calcium Regulates Transcriptional Repression of Myocyte Enhancer Factor 2 by Histone Deacetylase 4 J. Biol. Chem., July 14, 2000; 275(29): 22563 - 22567. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Brinkmann, A. L. Dahler, C. Popa, M. M. Serewko, P. G. Parsons, B. G. Gabrielli, A. J. Burgess, and N. A. Saunders Histone Hyperacetylation Induced by Histone Deacetylase Inhibitors Is Not Sufficient to Cause Growth Inhibition in Human Dermal Fibroblasts J. Biol. Chem., June 15, 2001; 276(25): 22491 - 22499. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Fischle, F. Dequiedt, M. Fillion, M. J. Hendzel, W. Voelter, and E. Verdin Human HDAC7 Histone Deacetylase Activity Is Associated with HDAC3 in Vivo J. Biol. Chem., September 14, 2001; 276(38): 35826 - 35835. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Furumai, Y. Komatsu, N. Nishino, S. Khochbin, M. Yoshida, and S. Horinouchi Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin PNAS, January 2, 2001; 98(1): 87 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhou, P. A. Marks, R. A. Rifkind, and V. M. Richon Cloning and characterization of a histone deacetylase, HDAC9 PNAS, September 11, 2001; 98(19): 10572 - 10577. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |